Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 394

Gastroenterology

  • Home
  • Gastroenterology
Headache Relief Shampoo Voted #1 Best New Product in 2019

Dr. D’s Medicated Headache Relief Shampoo is now available. This medicated shampoo will help alleviate headaches simply by soaking it on your head. Finding relief from minor to severe headaches shouldn’t always involve reaching for a bottle of pills. Dr. D is here to give you another option. Our proprietary formula will leave your head feeling better.

BUY NOW! http://headachereliefshampoo.com/product/headache-relief-shampoo/

January 1, 2019 / by / in
Napoleon Measurement of Gastrojejunal Anastomosis
Conditions:   Gastric Bypass;   Weight Regain
Interventions:   Device: Napoleon;   Other: Visual estimation
Sponsors:   NYU Langone Health;   Brigham and Women’s Hospital
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 16, 2021 / by / in
ConMed Beamer Study
Conditions:   Gastrointestinal Neoplasms;   Achalasia;   Gastroparesis
Intervention:  
Sponsors:   Baylor College of Medicine;   ConMed Corporation
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 15, 2021 / by / in
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab in Participants With Advanced Solid Tumors
Conditions:   Cervical Cancer;   Gastric/Gastroesophageal Junction Adenocarcinoma;   Microsatellite Stable Colorectal Cancer;   Non-Small-Cell Lung Cancer;   Squamous Cell Carcinoma of Head and Neck
Interventions:   Drug: BMS-986340;   Drug: BMS-936558-01
Sponsor:   Bristol-Myers Squibb
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 15, 2021 / by / in
A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma
Conditions:   Pancreatic Ductal Adenocarcinoma;   Colorectal Adenocarcinoma;   Gastric Adenocarcinoma;   Clinical Stage II Gastric Cancer AJCC v8;   Clinical Stage IIA Gastric Cancer AJCC v8;   Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8;   Clinical Stage IIB Gastric Cancer AJCC v8;   Clinical Stage III Esophageal Adenocarcinoma AJCC v8;   Clinical Stage III Gastric Cancer AJCC v8;   Malignant Solid Neoplasm;   Pathologic Stage II Gastric Cancer AJCC v8;   Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IIB Gastric Cancer AJCC v8;   Pathologic Stage III Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage III Gastric Cancer AJCC v8;   Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IIIA Gastric Cancer AJCC v8;   Pathologic Stage IIIB Gastric Cancer AJCC v8;   Pathologic Stage IIIC Gastric Cancer AJCC v8;   Stage I Pancreatic Cancer AJCC v8;   Stage IA Pancreatic Cancer AJCC v8;   Stage IB Pancreatic Cancer AJCC v8;   Stage II Pancreatic Cancer AJCC v8;   Stage IIA Pancreatic Cancer AJCC v8;   Stage IIB Pancreatic Cancer AJCC v8;   Stage III Colorectal Cancer AJCC v8;   Stage III Pancreatic Cancer AJCC v8;   Stage IIIA Colorectal Cancer AJCC v8;   Stage IIIB Colorectal Cancer AJCC v8;   Stage IIIC Colorectal Cancer AJCC v8;   Stage IV Colorectal Cancer AJCC v8;   Stage IVA Colorectal Cancer AJCC v8;   Stage IVB Colorectal Cancer AJCC v8
Intervention:   Biological: Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE
Sponsor:   Thomas Jefferson University
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 8, 2021 / by / in
CONFIRM: Magnetic Resonance Guided Radiation Therapy
Conditions:   Gastric Cancer;   Invasive Breast Cancer;   in Situ Breast Cancer;   Mantle Cell Lymphoma;   Larynx Cancer;   Bladder Cancer
Intervention:   Radiation: Viewray MRIdian® Linac
Sponsor:   Dana-Farber Cancer Institute
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 3, 2021 / by / in
A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2)
Condition:   Advanced Solid Tumors
Interventions:   Biological: ALKS 4230;   Biological: Pembrolizumab
Sponsor:   Alkermes, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 29, 2021 / by / in
Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer
Condition:   Gastric Cancer
Interventions:   Drug: IDX-1197+XELOX;   Drug: IDX-1197+Irinotecan
Sponsor:   Idience Co., Ltd.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 28, 2021 / by / in
A First in Human Study of BAY2701439 to Look at Safety, How the Body Absorbs, Distributes and Excretes the Drug, and How Well the Drug Works in Participants With Advanced Cancer Expressing the HER2 Protein
Condition:   Cancers With HER2 Expression
Interventions:   Drug: BAY2701439;   Drug: BAY2701438
Sponsor:   Bayer
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 28, 2021 / by / in
Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2
Conditions:   Sequelae of; Infection;   Post Infection Glomerulonephritis;   Post-Infectious Peripheral Neuralgia;   Post-Infectious Disorder (Disorder);   Post-Infectious Arthritis;   Post-Infectious Polyneuritis;   Post-Infectious Parkinsonism;   Post-Infectious Hypothyroidism;   Post Infectious Osteoarthritis;   Anxiety Disorders;   Depression;   Depression, Anxiety;   Depression, Bipolar;   Insomnia;   GERD;   Gastro Esophageal Reflux;   Hepatitis;   Glomerulonephritis
Interventions:   Combination Product: PurWet;   Combination Product: FurFat;   Combination Product: PurApo;   Combination Product: PurPhl;   Combination Product: PurClo;   Combination Product: PurInf;   Combination Product: Smoliv
Sponsor:   All Natural Medicine Clinic, LLC
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 27, 2021 / by / in
Intestinal Permeability and Gastroparesis
Conditions:   Gastroparesis;   Healthy
Intervention:   Diagnostic Test: Labs, urine tests, upper endoscopy with biopsy and confocal laser endomicroscopy
Sponsor:   Mayo Clinic
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 21, 2021 / by / in